QNRX — Quoin Pharmaceuticals Ltd.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1671502 ·
Last close
$3.36
Market Cap
$16.14M
52W High
$23.50
52W Low
$3.25
ADV30
22,301
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -4,923,012 -4,870,759 34,747,044 10,099,800 6,049,261
Jun 2026 0 — -5,473,574 -5,371,042 11,969,562 3,845,606 8,036,891
Mar 2026 0 — -5,131,210 -4,997,735 15,692,891 3,124,523 6,919,759
Dec 2025 0 — -4,520,435 -4,348,373 20,390,569 3,818,096 7,270,663

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-15,273,747
Investing CF
$-593,769
Financing CF
$18,045,212
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-12.12
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-81,339,224
Inventory
—
Receivables
—
ST Investments
$6,954,476
EBIT TTM
$-19,145,144
Pretax Income TTM
$-18,665,315
Interest Exp TTM
—
Analysts
8

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -16,290,716 -15,804,655 20,390,569 7,270,663 13,119,906 -13,540,994
Dec 2024 0 -9,528,465 -8,962,472 15,709,338 6,504,665 9,204,673 -7,857,309
Dec 2023 0 -9,378,504 -8,686,573 12,169,229 6,505,213 5,664,016 -7,864,429
Dec 2022 0 -9,257,704 -9,381,496 14,458,063 7,051,289 7,406,774 -8,480,732
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
$-18,665,315
OpCashFlow TTM
—
Assets (Latest)
$11,969,562
Forward EPS
$-2.71

Peers — same industry

TickerNameMarket CapLastDaily %
VICP Vicapsys Life Sciences, Inc. $16.19M $0.50 —
CNTX Context Therapeutics Inc. $15.71M $0.17 —
NCEL NewcelX Ltd. $15.48M $2.68 —
MDNAF Medicenna Therapeutics Corp. $14.77M $0.16 —
BOLT Bolt Biotherapeutics, Inc. $14.73M $5.65 —

News headlines (Yahoo Finance, 1h cache)

Quoin Pharmaceuticals’ Latest NETHERTON NOW Video Details the Life of a Family Living with Netherton Syndrome
2026-11-06 13:30 · Yahoo
Quoin Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2026 Financial Results
2026-11-05 13:30 · Yahoo
Quoin Pharmaceuticals to Announce Corporate Update and Third Quarter 2026 Financial Results on Thursday, November 5, 2026
2026-10-29 12:30 · Yahoo
Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
2026-10-20 10:30 · Yahoo
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
2026-10-14 10:30 · Yahoo
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
2026-10-06 10:30 · Yahoo
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
2026-09-22 12:30 · Yahoo
Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU
2026-09-10 12:30 · Yahoo
CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
2026-09-08 18:12 · Yahoo
Quoin in line for priority review voucher if rare paediatric drug approved
2026-09-08 17:28 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.